Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

This session examines the current state of progress toward a functional cure for HIV, drawing on advances in immunology, ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

Andy Feds, a comedian born with HIV, married his wife Jasmine Collins-Badeau, who is not living with HIV, and they are looking forward to welcoming a child into their family with an HIV-negative ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

The tool can be used to find providers that offer HIV testing and medications that prevent the virus, which causes AIDS.

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...

Advocates warn the cuts to Florida’s AIDS Drug Assistance Program may increase health risks statewide and reduce access for thousands.

The National Assembly’s Standing Committee on National Health Services, Regulations and Coordination has voiced serious concern over ...